Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Therapeutics × Dermatologic × Clear all

Phase

Status

Completed 12 Unknown 3 Withdrawn 2 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4 Head & Neck 4 Gynecologic 3 Gastrointestinal 3 Tumor-Agnostic 2 Other hematologic neoplasm 2 Lymphoid 2 Genitourinary 2 Breast 2 Sarcoma 1 Other 1 Dermatologic 1 CNS 1

Conditions

Keratosis, Actinic 1

Interventions

pembrolizumab 56 Nivolumab 52 Ipilimumab 28 Cyclophosphamide 19 Specimen Handling 15 Magnetic Resonance Spectroscopy 14 cemiplimab 13 Biopsy 13 fludarabine 12 Opdualag 12 Radiosurgery 11 relatlimab 10 Blood Specimen Collection 10 aldesleukin 8 binimetinib 7 Interleukin-2 7 Paclitaxel 6 mogamulizumab 5 fludarabine phosphate 5 encorafenib 5 atezolizumab 5 Surgical Procedures, Operative 5 Standard of Care 5 Radiotherapy 5 Immunotherapy 5 Immunoglobulin G 5 CTLA-4 Antigen 5 Bevacizumab 5 tebentafusp 4 Temozolomide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡